Software rules unclear in EU device proposals
10 April 2013
- INTERVIEW: Medtech companies must wake up to changed EU regulatory environment
- ANALYSIS: are EU rules on SUD reprocessing more muddled than ever?
- Pharma must be consulted on companion Dx reg, EU Commission tells Parliament
- Predicting the future of EU genetic testing regulation - opportunities and pitfalls
Other Informa News